ORHB News and Press, ORHub From 04/20/23

BALTIMORE, MD / ACCESSWIRE / April 20, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on HippoFi, Inc., formerly known as ORHub, Inc. (OTC PINK:ORHB) , a cutting-...

2023-04-19 06:15:17 ET HippoFi's ( OTCPK:ORHB ) unit Pur Biologics said it was issued a US patent for a technology which activates immune cells. The issued patent launches Pur into the field of cell and immune therapies, the company added. "By activating immune cells, we ...

Patent thrusts PUR Biologics into the $200B immunotherapy market IRVINE, CA / ACCESSWIRE / April 19, 2023 / PUR Biologics, a wholly owned subsidiary of HippoFi (OTC PINK:ORHB) today announced the issuance of a groundbreaking technology which activates immune cells. This issued patent launche...

IRVINE, CA / ACCESSWIRE / April 13, 2023 / PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is pleased to announce the release of PURfiberXP™, a uniquely processed demineralized extracellular matrix (d-ECM) designed to support bone regeneration, cellular integrat...

IRVINE, CA / ACCESSWIRE / April 11, 2023 / HippoFi, Inc. (OTC Pink:ORHB), a diversified company focused on the biotech and fintech markets, is pleased to announce that it has achieved Pink Current status with the OTCMarkets, a major milestone in the company's growth and development. Achieving t...

IRVINE, CA / ACCESSWIRE / April 6, 2023 / PUR Biologics, a subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is proud to announce the launch of PURcore TM , a unique moldable synthetic with an interconnected micro-pore structure for spine surgery. PURcore TM allows for the rapid colonization of the ...

Expanded sales force fuels market growth. IRVINE, CA / ACCESSWIRE / January 12, 2023 / HippoFi, Inc. (formerly ORHub), (OTC PINK:ORHB), a diversified company focused on the biotech and fintech markets, launches 2023 with robust sales of its PUR Biologics line of products. "We have expanded ...

PURbridge ™ , an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company's revenue throughout 2023 IRVINE, CA / ACCESSWIRE / November 23, 2022 / HippoFi, Inc. (formerly ORHub), (OTC PINK:ORHB), a diversified company focused on...

HippoFi formerly ORHub ( OTCPK:ORHB ) has signed a strategic pact with Precision Spine. The move will help to accelerate growth and drive revenue by selling the entire PUR Biologics product line and future HippoFi innovations. HippoFi accesses Precision Spine's major ...

HippoFi accesses Precision Spine's major sales channels to speed its sales strategy & quickly drive revenue IRVINE, CA / ACCESSWIRE / October 5, 2022 / HippoFi, Inc. - formerly ORHub ® (OTC PINK:ORHB) announced today it has signed a strategic agreement with Precision Spine, In...